IA
CLBT icon

Investor AB’s Cellebrite CLBT Stock Holding History

Investor AB’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Buy
75,000
+20,000
+36% +$264K 0.01% 4
2026
Q1 		$758K Buy
+55,000
New +$829K 0.01% 4
2025
Q4 		– Sell
-40,000
Closed -$741K – 13
2025
Q3 		$741K Hold
40,000
– – 0.01% 6
2025
Q2 		$640K Buy
40,000
+5,000
+14% +$89.1K 0.01% 7
2025
Q1 		$680K Sell
35,000
-5,000
-13% -$105K 0.02% 7
2024
Q4 		$881K Buy
+40,000
New +$770K 0.02% 4

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Investor AB's CLBT Position: Q2 2026 in Review

Investor AB increased its Cellebrite (CLBT) stake by 36% in Q2 2026, buying an estimated $264K and bringing the position to 75,000 shares worth $1.09M. The position accounts for 0.01% of the portfolio, ranked #4.

Investor AB first reported a position in CLBT in Q4 2024 and has held it in 6 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Investor AB held 75,000 shares of Cellebrite worth $1.09M as of Q2 2026.
  • Investor AB bought 20,000 Cellebrite shares in Q2 2026, an estimated $264K.
  • Cellebrite made up 0.01% of Investor AB's portfolio in Q2 2026, its #4 holding.
  • Investor AB first reported a position in Cellebrite in Q4 2024 and has held it in 6 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Investor AB's 13F filing for Q2 2026, filed 14 Aug 2026.